Search research articles
Contact Us
Filters
Showing results (481-490 of 595) with videos related to
Page
of 60
Sort By:
Genes, Chromosomes & Cancer
|
January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia
Andreas Reiter, Susanne Saussele, David Grimwade, et al.
Leukemia
|
July 2, 2005
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
F M Ross, A H Ibrahim, A Vilain-Holmes, et al.
The Medical Journal of Australia
|
October 7, 2019
Project Synergy: co-designing technology-enabled solutions for Australian mental health services reform
Ian B Hickie, Tracey A Davenport, Jane M Burns, et al.
Trials
|
May 16, 2019
POPPIE: protocol for a randomised controlled pilot trial of continuity of midwifery care for women at increased risk of preterm birth
C Fernandez Turienzo, D Bick, M Bollard, et al.
Leukemia
|
January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M Jawhar, J Schwaab, S Schnittger, et al.
Hemasphere
|
November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet
Raphael Itzykson, Pierre Fenaux, David Bowen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 18, 2016
Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
Seth Heldenbrand, Chenghui Li, Rosemary P Cross, et al.
Blood
|
July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
Animesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood
|
October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
David G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Genes, Chromosomes & Cancer
|
September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms
Nicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Page
of 60
Search research articles
Search
Showing results (481-490 of 595) with videos related to
Sort By:
Page
of 60
Genes, Chromosomes & Cancer
|
January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia
Andreas Reiter, Susanne Saussele, David Grimwade, et al.
Leukemia
|
July 2, 2005
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
F M Ross, A H Ibrahim, A Vilain-Holmes, et al.
The Medical Journal of Australia
|
October 7, 2019
Project Synergy: co-designing technology-enabled solutions for Australian mental health services reform
Ian B Hickie, Tracey A Davenport, Jane M Burns, et al.
Trials
|
May 16, 2019
POPPIE: protocol for a randomised controlled pilot trial of continuity of midwifery care for women at increased risk of preterm birth
C Fernandez Turienzo, D Bick, M Bollard, et al.
Leukemia
|
January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M Jawhar, J Schwaab, S Schnittger, et al.
Hemasphere
|
November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet
Raphael Itzykson, Pierre Fenaux, David Bowen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 18, 2016
Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
Seth Heldenbrand, Chenghui Li, Rosemary P Cross, et al.
Blood
|
July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
Animesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood
|
October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
David G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Genes, Chromosomes & Cancer
|
September 11, 2015
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms
Nicole Naumann, Juliana Schwaab, Georgia Metzgeroth, et al.
Page
of 60